Exploring the impact of real-life dosing conditions on intraluminal and systemic concentrations of atazanavir in parallel with gastric motility recording in healthy subjects

Abstract
No abstract available
Funding Information
  • Flemish Research Council (12R2119N, G078417N)
  • internal funds of KU Leuven (PDM/17/164)
  • Innovative Medicines Initiative Joint Undertaking (115369)